Guardant Health Data at ASCO and AACR Demonstrates Growing Value of Liquid Biopsy for Precision Oncology in Advanced and Early Stage Cancer
REDWOOD CITY, Calif., May 15, 2020 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH) along with leading academic institutions and pharmaceutical […]